Tengion, Inc.

OTC: TNGNQ · Healthcare · Biotechnology

PublicHQ Winston-Salem, Reports USD

#1143 of 1,394 Healthcare companies by revenue

EA Score

——

FH —DQ —GM —SS 20

v0.1 · 5/100 weight · pillars only

↑ disclosure history, workforce scale · ↓ Piotroski F, listing tenure

Methodology →

Revenue TTM

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

-$26.5M

Employees

Market cap

$4.0k

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$0$02013

Net income-$26.5M-$26.5M2013

Operating income-$16.6M-$16.6M2013

Total assets$25.7M$25.7M2013

Liabilities$42.6M$42.6M2013

Equity-$16.9M-$16.9M2013

Revenue trend

FY2007 – FY2013 · USD

FY07

FY08

FY09

FY10

FY11

FY12

FY13

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Tengion, Inc. booked $0 in FY2013 revenue — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.

Peers · Healthcare

Nemaura Medical Inc.——Xeno Transplants Corporation——Cyclo3pss Corporation——Skylight Health Group Inc.——

Key facts

CEODavid I. Scheer

SectorHealthcare

IndustryBiotechnology

HeadquartersWinston-Salem, null

ExchangeOTC: TNGNQ

Employees25

IPO date2022-11-23

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.